Man Group
VNDA icon

Man Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Man Group’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$553K Buy
+80,060
New +$617K ﹤0.01% 2051
2025
Q2 		– Sell
-17,361
Closed -$79.7K – 2404
2025
Q1 		$79.7K Buy
+17,361
New +$80.9K ﹤0.01% 2120
2024
Q2 		– Sell
-47,730
Closed -$196K – 2288
2024
Q1 		$196K Buy
+47,730
New +$191K ﹤0.01% 2012
2023
Q3 		– Sell
-273,121
Closed -$1.52M – 1297
2023
Q2 		$1.8M Buy
+273,121
New +$1.75M 0.01% 1237
2023
Q1 		– Sell
-155,885
Closed -$1.1M – 1536
2022
Q4 		$1.15M Buy
155,885
+30,687
+25% +$299K ﹤0.01% 1279
2022
Q3 		$1.24M Buy
+125,198
New +$1.32M 0.01% 1213
2022
Q2 		– Sell
-55,318
Closed -$573K – 1316
2022
Q1 		$625K Buy
+55,318
New +$727K ﹤0.01% 1522
2021
Q2 		– Sell
-28,880
Closed -$434K – 2105
2021
Q1 		$434K Sell
28,880
-294,392
-91% -$4.77M ﹤0.01% 1519
2020
Q4 		$4.25M Sell
323,272
-21,400
-6% -$258K 0.02% 898
2020
Q3 		$3.33M Sell
344,672
-22,000
-6% -$235K 0.01% 1008
2020
Q2 		$4.2M Sell
366,672
-44,880
-11% -$508K 0.02% 756
2020
Q1 		$4.26M Buy
411,552
+119,905
+41% +$1.49M 0.03% 544
2019
Q4 		$4.79M Buy
291,647
+161,927
+125% +$2.45M 0.02% 1008
2019
Q3 		$1.72M Buy
+129,720
New +$1.81M 0.01% 1298
2019
Q2 		– Sell
-14,721
Closed -$271K – 2016
2019
Q1 		$271K Sell
14,721
-69,499
-83% -$1.58M ﹤0.01% 1828
2018
Q4 		$2.2M Sell
84,220
-111,815
-57% -$2.63M 0.01% 1174
2018
Q3 		$4.5M Sell
196,035
-108,537
-36% -$2.22M 0.02% 1054
2018
Q2 		$5.8M Sell
304,572
-212,028
-41% -$3.55M 0.02% 866
2018
Q1 		$8.71M Buy
+516,600
New +$8.65M 0.04% 554

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's VNDA Position: Q1 2026 in Review

Man Group opened a new position in Vanda Pharmaceuticals (VNDA) in Q1 2026: 80,060 shares worth $553K. The stake represents ﹤0.01% of the portfolio and ranks #2051 among its holdings. This is a return to the name: Man Group previously reported a position in VNDA as recently as Q1 2025.

Man Group first reported a position in VNDA in Q1 2018 and has held it in 19 quarters since. The position peaked at $8.71M in Q1 2018. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Man Group held 80,060 shares of Vanda Pharmaceuticals worth $553K as of Q1 2026.
  • Vanda Pharmaceuticals was a new Man Group position in Q1 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2051 holding.
  • Man Group first reported a position in Vanda Pharmaceuticals in Q1 2018 and has held it in 19 quarters since.
  • Man Group's Vanda Pharmaceuticals position peaked at $8.71M in Q1 2018.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.